Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHERINE ANNE HEMBY

Allopathic & Osteopathic Physicians Family Medicine

NPI
1851698195
CMS profile
39216
Location
LAGRANGE, GA

General Payments · PY2018–2023

$5,313.16

  • Reported across 174 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$511.84

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $511.84 15

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $233.83 4
Exact Sciences Corporation $103.08 2
ABBVIE INC. $39.74 2
SANOFI-AVENTIS U.S. LLC $39.53 2
Novo Nordisk AS $31.81 2
Bayer HealthCare Pharmaceuticals Inc. $24.40 1
GlaxoSmithKline, LLC. $22.62 1
Lilly USA, LLC $16.83 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,453.80 43
PY2019 $1,428.89 59
PY2020 $653.12 28
PY2021 $817.11 23
PY2022 $448.40 6
PY2023 $511.84 15

Payment records · PY2023 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.87 03/11/2023 Food and Beverage Undisputed 01/23/2026 997462665 CMS
ABBVIE INC. $20.87 05/23/2023 Food and Beverage Undisputed 01/23/2026 997462667 CMS
AstraZeneca Pharmaceuticals LP $72.97 01/05/2023 Food and Beverage Undisputed 01/23/2026 1011299551 CMS
AstraZeneca Pharmaceuticals LP $20.61 02/15/2023 Food and Beverage Undisputed 01/23/2026 1015902125 CMS
AstraZeneca Pharmaceuticals LP $15.26 03/30/2023 Food and Beverage Undisputed 01/23/2026 1015853489 CMS
AstraZeneca Pharmaceuticals LP $124.99 05/03/2023 Food and Beverage Undisputed 01/23/2026 1016162713 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.40 04/21/2023 Food and Beverage Undisputed 01/23/2026 1000175861 CMS
Exact Sciences Corporation $13.49 02/10/2023 Food and Beverage Undisputed 01/23/2026 1026562677 CMS
Exact Sciences Corporation $89.59 03/29/2023 Food and Beverage Undisputed 01/23/2026 1026562719 CMS
GlaxoSmithKline, LLC. $22.62 02/22/2023 Food and Beverage Undisputed 01/23/2026 1002205913 CMS
Lilly USA, LLC $16.83 02/07/2023 Food and Beverage Undisputed 01/23/2026 1031808505 CMS
Novo Nordisk Inc $15.65 02/17/2023 Food and Beverage Undisputed 01/23/2026 1000316325 CMS
Novo Nordisk Inc $16.16 04/28/2023 Food and Beverage Undisputed 01/23/2026 1000316329 CMS
SANOFI-AVENTIS U.S. LLC $21.50 02/10/2023 Food and Beverage Undisputed 01/23/2026 1050143045 CMS
SANOFI-AVENTIS U.S. LLC $18.03 04/18/2023 Food and Beverage Undisputed 01/23/2026 1050143069 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.